Phase 3 Malformation Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 2Phase 3
Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
Lymphatic Malformations
Novartis Pharmaceuticals232 enrolled56 locationsNCT05948943
Recruiting
Phase 3
Systematic Approach for Children With Orbital Malformation With Sirolimus Use
Orbital Lymphatic Malformation
Ain Shams University30 enrolled1 locationNCT07378657
Recruiting
Phase 2Phase 3
Efficacy and Safety of Anti-angiogenic Therapy With IV Bevacizumab in Patients With Symptomatic Cerebral Arteriovenous Malformations
Cerebral AV Malformation
Fondation Ophtalmologique Adolphe de Rothschild54 enrolled1 locationNCT06264531
Recruiting
Phase 2Phase 3
Different Doses of Sirolimus for the Treatment of Cystic Lymphatic Malformations
Lymphatic Malformation
West China Hospital150 enrolled1 locationNCT06673290
Recruiting
Phase 3
Efficacy and Safety of Sirolimus in Vascular Anomalies That Are Refractory to Standard Care
Vascular Malformations
Cliniques universitaires Saint-Luc- Université Catholique de Louvain250 enrolled3 locationsNCT02638389